Influence of smoking and obesity on treatment response in patients with axial spondyloarthritis: a systematic literature review
| dc.contributor.author | Zurita Prada, Pablo | |
| dc.contributor.author | Urrego Laurín, Claudia | |
| dc.contributor.author | Guillén Astete, Carlos Antonio | |
| dc.contributor.author | Kanaffo Caltelblanco, S. | |
| dc.contributor.author | Navarro Compán, Victoria | |
| dc.date.accessioned | 2021-07-28T16:00:48Z | |
| dc.date.available | 2021-07-28T16:00:48Z | |
| dc.date.issued | 2021 | |
| dc.description.abstract | Background: Congenital cytomegalovirus infection (CMVc) affects 0.7%-6% of recent births. Among its clinical manifestations are low weight and length at birth. Objective: Describe the growth patterns of children with CMVc in their early years. Methods: Observational, multicenter study of patients with CMVc. Anthropometric data were collected during the first 2 years of life and compared with World Health Organization standards. Results: Anthropometric characteristics of 383 children with CMVc were studied, of which 198 (51%) were symptomatic at birth. At birth, 9% were small for gestational age (SGA) in terms of their weight and length and 17% had microcephaly. At 24 ± 3 months, 10% had a weight and length ≤2 SD, and 13% a head circumference ≤2 SD. Of those who were SGA at birth, at 24 ± 3 months >20% remained at ≤2 SD of their weight and length. Conversely, 75% of children with low weight or length at 24 ± 3 had not been SGA at birth. 20% of infants with microcephaly at birth remained with microcephaly, and 10% of those without microcephaly developed it at 24 ± 3 months. The average growth rate in length and weight was normal. Patients who were symptomatic at birth, premature and with motor and neurocognitive impairment had a significantly higher risk of low weight and length at 24 ± 3 months. Conclusion: Around 10% of children with CMVc are at ≤2 SD in weight, length and head circumference at 24 ± 3 months. The lack of adequate growth is associated with symptoms at birth, prematurity and motor and neurocognitive impairment. Growth impairment could be incorporated into the symptomatic spectrum of CMVc. | spa |
| dc.description.filiation | UEM | spa |
| dc.description.impact | 3.650 JCR (2021) Q3, 20/34 Rheumatology | spa |
| dc.description.impact | 0.873 SJR (2021) Q1, 591/2489 Medicine (miscellaneous) | spa |
| dc.description.impact | No data IDR 2021 | spa |
| dc.description.sponsorship | Sin financiación | spa |
| dc.identifier.citation | Zurita Prada, P., Urrego Laurín, C., Guillén Astete, C. A., Kanaffo Caltelblanco, S., & Navarro Compán, V. (2021). Influence of smoking and obesity on treatment response in patients with axial spondyloarthritis: a systematic literature review. Clinical Rheumatology, 40(5), 1673-1686. https://doi.org/10.1007/s10067-020-05319-6 | spa |
| dc.identifier.doi | 10.1007/s10067-020-05319-6 | |
| dc.identifier.issn | 0770-3198 | |
| dc.identifier.issn | 1434-9949 | |
| dc.identifier.uri | http://hdl.handle.net/11268/10261 | |
| dc.language.iso | eng | spa |
| dc.peerreviewed | Si | spa |
| dc.relation.publisherversion | http://ezproxy.universidadeuropea.es/login?url=https://doi.org/10.1007/s10067-020-05319-6 | spa |
| dc.rights.accessRights | restricted access | spa |
| dc.subject.other | Espondiloartritis | spa |
| dc.subject.unesco | Tabaquismo | spa |
| dc.subject.unesco | Obesidad | spa |
| dc.title | Influence of smoking and obesity on treatment response in patients with axial spondyloarthritis: a systematic literature review | spa |
| dc.type | journal article | spa |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | 3ce91659-ea76-4a54-a232-84df806bc9d9 | |
| relation.isAuthorOfPublication | f66c1f06-c006-4b7a-8f8d-125a879a9c18 | |
| relation.isAuthorOfPublication.latestForDiscovery | 3ce91659-ea76-4a54-a232-84df806bc9d9 |

